Dongbo Wang, PhD

Director Regulatory Affairs
Histosonics

Dongbo Wang, Ph.D. is the Director of Regulatory Affairs at Histosonics. Prior to joining industry, he worked in FDA/CDER/OPEQ regulating dental, general surgical, and respiratory devices. Throughout his FDA career, he primarily reviewed CDRH premarket submissions – 510(k)s, IDEs, de novos, PMAs, and combination products (device-led, drug-led, and biologics led). He is very much enjoying the transition to industry and collaborating to create innovative medical devices.

Presentation(s):

• Survivor: The FDA 510(k) Program Edition (Day 1 of 2)

  Monday, September 16, 2024
  8:30 AM – 4:00 PM PDT

• Survivor: The FDA 510(k) Program Edition (Day 2 of 2)

  Tuesday, September 17, 2024
  8:30 AM – 4:00 PM PDT